ACCESS DX LABORATORY LLC
NPI 1700329901
Clinical Medical Laboratory in Houston, TX

NPI Status: Active since November 21, 2016

Contact Information

8920 KIRBY DR
HOUSTON, TX
ZIP 77054
Phone: (346) 571-6627
Fax: (832) 652-3627

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • Accepts Insurance
  • CLIA Number: 45D2034771
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 02-15-2028

About ACCESS DX LABORATORY LLC

This page provides the complete NPI Profile along with additional information for Access Dx Laboratory Llc, a provider established in Houston, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1700329901 assigned on November 2016. The practitioner's primary taxonomy code is 291U00000X with license number 45D2034771 (TX). The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Bryon A. Cipriani (Authorized Official)

NPI
1700329901
Provider Name
ACCESS DX LABORATORY LLC
Entity Type
Organization
Location Address
8920 KIRBY DR HOUSTON, TX 77054
Location Phone
(346) 571-6627
Location Fax
(832) 652-3627
Mailing Address
4035 WILLOWBEND BLVD STE 400 HOUSTON, TX 77025
Mailing Phone
(346) 571-6627
Mailing Fax
(832) 652-3627
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
11-21-2016
Last Update Date
05-31-2023
Code Navigator

Establishments like Access Dx Laboratory Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
License No.
45D2034771
License State
TX
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Insurance Plans Accepted

According to publicly available information the provider might be accepting the following health plans from these health insurance companies:

  • WellSense Clarity NH Bronze 6500 HSA + $0 Rx List + 24/7 Nurse Advice - HMO
  • WellSense Clarity NH Bronze 7500 HSA + $0 Rx List + 24/7 Nurse Advice - HMO
  • WellSense Clarity NH Bronze 7600 HSA + $0 Rx List + 24/7 Nurse Advice - HMO
  • WellSense Clarity NH Gold 2000 + $0 Rx List + 24/7 Nurse Advice - HMO
  • WellSense Clarity NH Silver 0 Deductible + $0 Rx List + 24/7 Nurse Advice - HMO
  • WellSense Clarity NH Silver 3400 + $0 Rx List + 24/7 Nurse Advice - HMO
  • WellSense Clarity NH Silver 6000 + $0 Rx List + 24/7 Nurse Advice - HMO

*Please verify directly with this provider to make sure your insurance plan is currently accepted.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

BRYON A. CIPRIANI

Authorized Official Title
AUTHORIZED OFFICIAL
Authorized Official Phone
(346) 571-6627

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen

This is a lab test that detects the presence of COVID-19 in your body. It uses a technique to amplify the virus's genetic material, either DNA or RNA, making it easier to identify. A positive result indicates an active infection.

This service was performed 89 times for 57 patients

Blood test, basic group of blood chemicals (calcium, total)

A basic group blood test measures the levels of certain chemicals in your blood, including calcium. This helps assess your overall health and detect potential problems. The procedure involves drawing a small amount of blood from your arm, which is then analyzed in a lab.

This service was performed 22 times for 19 patients

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

A Complete Blood Cell Count is a common test that measures various components of the blood, including red cells (carry oxygen), white cells (fight infection), and platelets (help blood clot). An automated test ensures accuracy. The differential count provides detailed information about white cell types.

This service was performed 56 times for 40 patients

Detection of mycoplasma genitalium by dna or rna probe

This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.

This service was performed 252 times for 215 patients

Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique

This test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.

This service was performed 76 times for 69 patients

Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique

A detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.

This service was performed 75 times for 68 patients

Detection test by nucleic acid for herpes simplex virus, amplified probe technique

This test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.

This service was performed 75 times for 68 patients

Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique

A detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.

This service was performed 42 times for 42 patients

Detection test by nucleic acid for multiple organisms, amplified probe(s) technique

This is a test that identifies various microorganisms in your body using a method called amplified probe technique. It targets specific genetic material (nucleic acids) of the organisms, amplifying them for easy detection. This helps in diagnosing infections accurately.

This service was performed 106 times for 99 patients

Detection test by nucleic acid for multiple types influenza virus

A detection test by nucleic acid for multiple types of influenza virus is a diagnostic procedure. It identifies the genetic material of the virus in your body. It's highly accurate and can distinguish between different flu strains, helping in prompt and precise treatment.

This service was performed 22 times for 20 patients

Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets

This test identifies different respiratory viruses by examining their nucleic acid, the building blocks of their genetic material. It can detect multiple types or subtypes, specifically 3-5 targets. This helps in diagnosing your respiratory illness accurately.

This service was performed 49 times for 49 patients

Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique

This test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.

This service was performed 42 times for 42 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 2,981 times for 240 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 251 times for 221 patients

Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique

A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.

This service was performed 212 times for 185 patients

Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique

This test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.

This service was performed 250 times for 221 patients

Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique

A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.

This service was performed 249 times for 220 patients

Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique

This is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.

This service was performed 75 times for 68 patients

Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique

The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.

This service was performed 329 times for 283 patients

Detection test for candida species (yeast), amplified probe technique

This test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.

This service was performed 1,039 times for 230 patients

Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants

Gene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.

This service was performed 179 times for 179 patients

Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants

Gene analysis of cytochrome P450 2C19 common variants is a test that helps understand how your body processes certain medications. This can help your doctor tailor treatments specifically for you, improving their effectiveness and safety.

This service was performed 82 times for 82 patients

Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants

Gene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.

This service was performed 158 times for 158 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 488 times for 296 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 504 times for 307 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
45D2034771
Facility Type
Independent
Certificate Effective Date
February 16, 2026
Certificate Expiration Date
February 15, 2028
Laboratory Director
DR. LAKSHMI CHANDRAMOHAN
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Access Dx Laboratory Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for ACCESS DX LABORATORY LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1700329901, we treat the final digit (1) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 59. The final step is to find the difference between that total and the next multiple of ten (60 - 59 = 1).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
7
Unchanged
Pos 3
0
Doubled → 0
Pos 4
0
Unchanged
Pos 5
3
Doubled → 6
Pos 6
2
Unchanged
Pos 7
9
Doubled → 18 → 1 + 8
Pos 8
9
Unchanged
Pos 9
0
Doubled → 0
Check
1
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 0 → 0 3 → 6 9 → 18 → 9 0 → 0

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 7 + 0 + 0 + 6 + 2 + 1 + 8 + 9 + 0 + 24 = 59

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 59 is 60. The difference is the calculated check digit.

60 - 59 = 1
This NPI is valid
The calculated check digit is 1, which matches the last digit of 1700329901.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1700329901, enumerated as an "organization" on November 21, 2016.

The provider is located at 8920 KIRBY DR HOUSTON, TX 77054 and the phone number is (346) 571-6627.

Clinical Medical Laboratory with taxonomy code 291U00000X.

The provider might be accepting Accepts: WellSense Health Plan. Please consult your insurance carrier or call the provider to verify.